Theratechnologies Inc
TSX:TH
Theratechnologies Inc
Revenue
Theratechnologies Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Theratechnologies Inc
TSX:TH
|
Revenue
$78.1m
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
27%
|
|
Zymeworks Inc
NYSE:ZYME
|
Revenue
$76m
|
CAGR 3-Years
25%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Revenue
$51.1m
|
CAGR 3-Years
700%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Revenue
$2.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Revenue
$175.5m
|
CAGR 3-Years
52%
|
CAGR 5-Years
223%
|
CAGR 10-Years
68%
|
|
Spectral Medical Inc
TSX:EDT
|
Revenue
CA$1.6m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-5%
|
See Also
What is Theratechnologies Inc's Revenue?
Revenue
78.1m
USD
Based on the financial report for Feb 29, 2024, Theratechnologies Inc's Revenue amounts to 78.1m USD.
What is Theratechnologies Inc's Revenue growth rate?
Revenue CAGR 10Y
27%
Over the last year, the Revenue growth was -4%. The average annual Revenue growth rates for Theratechnologies Inc have been 6% over the past three years , 8% over the past five years , and 27% over the past ten years .